Search
Menu
Teledyne DALSA - Linea HS2 11/24 LB

Low-Cost SPR Services Offered in Colorado

Facebook X LinkedIn Email
BOULDER, Colo., July 23, 2013 — BiOptix has announced a partnership with the University of Colorado at Denver to offer low-cost surface plasmon resonance (SPR) services to Colorado-based researchers in academia and industry.

The SPR services offered through the research collaboration with the Biophysics Shared Resource Core Facility at the university’s Anschutz Medical Campus are based on BiOptix’s 404pi, a next-generation SPR platform designed and built in Colorado to provide label-free analysis of protein-protein kinetics and protein-small molecule interactions.

“By offering the use of the new BiOptix 404pi to researchers based in Colorado, BiOptix can both support as well as foster scientific research and activity here in our home state,” said Ken Wilczek, vice president of sales and marketing.

The Biophysics Shared Resource Facility is a user facility owned and operated by the university’s Program in Structural Biology and Biochemistry. Since opening in 2001, the group has developed resources to study biomolecular structure and thermodynamics through SPR, fluorescence spectroscopy, analytical ultracentrifugation, circular dichroism/optical rotary dispersion, and isothermal titration calorimetry and differential scanning calorimetry. In addition, the group also offers mass spectroscopy, liquid chromatography-tandem mass spectrometry, high-performance liquid chromatography and amino acid analysis services.

For more information, visit: www.bioptix.com
Excelitas Technologies Corp. - X-Cite Vitae  MR 11/24

Published: July 2013
AmericasBasic ScienceBiophotonicsBiophysics Shared Resource Core FacilityBiOptixBusinessColoradoImagingKen WilczekspectroscopySPRsurface plasmon resonanceUniversity of Colorado Denver

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.